Xylem (XYL) r&d spend was $226M in FY2025 (-2% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2025
$226M
-2%
2024
$230M
-1%
2023
$232M
+13%
2022
$206M
+1%
2021
$204M
+9%
2020
$187M
-2%
2019
$191M
+1%
2018
$189M
+4%
2017
$181M
+65%
2016
$110M
+16%
2015
$95M
-9%
2014
$104M
+0%
2013
$104M
-2%
2012
$106M
+6%
2011
$100M
+35%
2010
$74M
+17%
2009
$63M
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q2 2026
$59M
Q1 2026
$56M
Q4 2025
$60M
Q3 2025
$52M
Q2 2025
$58M
Q1 2025
$56M
Q4 2024
$58M
Q3 2024
$55M
Q2 2024
$58M
Q1 2024
$59M
Q4 2023
$60M
Q3 2023
$61M
Source: XYL on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.